Driehaus Capital Management LLC Day One Biopharmaceuticals, Inc. Transaction History

Driehaus Capital Management LLC

$9.13 Billion
Q1 2024

A detailed history of Driehaus Capital Management LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Driehaus Capital Management LLC holds 719,011 shares of DAWN stock, worth $10.6 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

719,011

Previous 483,239 48.79%

Holding current value

$10.6 Million

Previous $7.06 Million 68.36%

% of portfolio

0.13%

Previous 0.09%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.56 - $17.46 $3.2 Million - $4.12 Million	235,772 Added 48.79%	719,011 $11.9 Million
Q4 2023 Feb 14, 2024	SELL	$9.68 - $15.37 $49,164 - $78,064	-5,079 Reduced 1.04%	483,239 $7.06 Million
Q3 2023 Nov 14, 2023	BUY	$11.22 - $14.86 $114,578 - $151,750	10,212 Added 2.14%	488,318 $5.99 Million
Q2 2023 Aug 14, 2023	BUY	$11.74 - $14.47 $73,046 - $90,032	6,222 Added 1.32%	478,106 $5.71 Million
Q1 2023 May 15, 2023	SELL	$12.75 - $23.41 $147,900 - $271,556	-11,600 Reduced 2.4%	471,884 $6.31 Million

Q4 2022 Feb 14, 2023	SELL	$18.77 - $22.0 $121,779 - $142,736	-6,488 Reduced 1.32%	483,484 $10.4 Million
Q3 2022 Nov 14, 2022	SELL	$16.44 - $26.57 $192,627 - $311,320	-11,717 Reduced 2.34%	489,972 $9.81 Million
Q2 2022 Aug 15, 2022	BUY	$5.72 - $17.9 $561,881 - $1.76 Million	98,231 Added 24.35%	501,689 $8.98 Million
Q1 2022 May 16, 2022	SELL	$9.12 - $17.47 $70,670 - $135,375	-7,749 Reduced 1.88%	403,458 $4 Million
Q4 2021 Feb 14, 2022	SELL	$15.65 - $26.33 $316,740 - $532,892	-20,239 Reduced 4.69%	411,207 $6.93 Million
Q3 2021 Nov 15, 2021	SELL	$20.0 - $27.92 $59,540 - $83,117	-2,977 Reduced 0.69%	431,446 $10.2 Million
Q2 2021 Aug 16, 2021	BUY	$19.0 - $23.69 $8.25 Million - $10.3 Million	434,423 New	434,423 $9.89 Million

Others Institutions Holding DAWN

# of Institutions

148

Shares Held

60M

Call Options Held

47.7K

Put Options Held

61.3K

View Full List

About Day One Biopharmaceuticals, Inc.

Ticker DAWN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,461,104
Market Cap $1.09B
Description
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...

More about DAWN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.

Account

Driehaus Capital Management LLC Day One Biopharmaceuticals, Inc. Transaction History